| Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 52.75 mm | 52.75 mm | 52.75 mm | 52.75 mm | 52.75 mm | 52.75 mm |
| Cash burn (monthly) | 10.92 mm | 715.33 k | 21.73 mm | 22.41 mm | 17.64 mm | 16.44 mm |
| Cash used (since last report) | 18.04 mm | 1.18 mm | 35.89 mm | 37.01 mm | 29.14 mm | 27.16 mm |
| Cash remaining | 34.71 mm | 51.57 mm | 16.86 mm | 15.74 mm | 23.61 mm | 25.59 mm |
| Runway (months of cash) | 3.2 | 72.1 | 0.8 | 0.7 | 1.3 | 1.6 |
| 13F holders | Current |
|---|---|
| Total holders | 173 |
| Opened positions | 28 |
| Closed positions | 15 |
| Increased positions | 62 |
| Reduced positions | 42 |
| 13F shares | Current |
|---|---|
| Total value | 389.71 bn |
| Total shares | 201.38 mm |
| Total puts | 52.80 k |
| Total calls | 75.80 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 23.77 mm | $50.63 bn |
| PFE Pfizer | 22.03 mm | $46.93 bn |
| TPG GP A | 18.72 mm | $39.87 bn |
| BlackRock | 18.06 mm | $38.47 bn |
| Lynx1 Capital Management | 10.87 mm | $23.16 bn |
| Vanguard | 8.00 mm | $17.04 bn |
| STT State Street | 7.25 mm | $15.44 bn |
| Seaview Trust | 7.04 mm | $105.05 mm |
| Capital World Investors | 6.90 mm | $14.69 bn |
| Citadel Advisors | 5.35 mm | $11.39 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Apr 25 | Annie Yoshiyama | Common Stock | Sell | Dispose S | No | No | 1.41 | 9,601 | 13.54 k | 130,663 |
| 14 Mar 25 | Benjamin Machinas Beneski | Common Stock | Sell | Dispose S | No | No | 1.975 | 5,488 | 10.84 k | 218,507 |
| 14 Mar 25 | Chang David D | Common Stock | Sell | Dispose S | No | No | 1.96 | 46,668 | 91.47 k | 5,276,569 |
| 1 Mar 25 | Benjamin Machinas Beneski | Common Stock | Grant | Acquire A | No | No | 0 | 31,755 | 0.00 | 223,995 |
| 1 Mar 25 | Benjamin Machinas Beneski | Stock Option Common Stock | Grant | Acquire A | No | No | 1.8 | 112,339 | 202.21 k | 112,339 |
